Dogwood Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.36

+0.00 (+0.00%)

As of Sep 28, 10:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,523.5% upside

Low Target $13.69

Average Target $22.08

High Target $22.84

Current Price $1.36

Current
$1.36

Target
$22.08

$13.69 $22.08 avg $22.84

Scenario Analysis

Bear Case

$13.69

906.6%

Low target

Base Case

$22.08

+1,523.5%

Avg target

Bull Case

$22.84

+1,579.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$9.50

-85.7% from high

52-Week Low

$1.28

+6.3% from low

Target vs 52W High

$22.08

+132.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%